Psy155 - Determining the Value of Emicizumab (Hemlibra®) for the Prophylaxis Treatment of Haemophilia a Patients With Inhibitors in Spain by Multi-Criteria Decision Analysis (Mcda)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2729

Related search